Treatment of lung tumor colonies with (90)Y targeted to blood vessels: Comparison with the α-particle emitter 213Bi

Nuclear Medicine and Biology

Volumn 26, Issue 1, 1999, Pages 149-157

  Kennel, Stephen J ^a   Stabin, Michael ^b   Yoriyaz, Helio ^c   Brechbiel, Martin ^d   Mirzadeh, Saed ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c INSTITUTO DE PESQUISAS ENERGÉTICAS E NUCLEARES   (Brazil)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Particle emitter; 90Y; Lung; Tumor; Yttrium 90

Indexed keywords

BISMUTH; MONOCLONAL ANTIBODY Y 90;

ALPHA RADIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; FEMALE; LUNG TUMOR; MOUSE; NONHUMAN; RADIATION DOSE; RADIOIMMUNOTHERAPY;

ANIMALS; ANTIBODIES, MONOCLONAL; BISMUTH; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; ISOTHIOCYANATES; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, SCID; PENTETIC ACID; RADIOISOTOPES; RADIOPHARMACEUTICALS; YTTRIUM RADIOISOTOPES;

EID: 0032892067     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00069-9     Document Type: Article

References (32)

1. Akabani G., Zalutsky M.R. Microdosimetry of astatine-211 using histological images Application to bone marrow . Radiat. Res. 148:1997;599-607.
2. Antoniw P., Farnsworth A.P.H., Turner A., Haines A.M.R., Mountain A., Mackintosh J., Shochat D., Humm J., Welt S., Old L.J., Yarranton G.T., King D.J. Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM). Brit. J. Cancer. 74:1996;513-524.
3. 213Bi. Radiochim. Acta. 79:1997;145-149.
4. Brechbiel M.W., Gansow O.A. Synthesis of C-functionalized trans-cyclohexyldiethylene-triaminepentacetic acids for labeling of monoclonal antibodies with the bismuth-212 α-particle emitter. J. Chem. Soc. Perkin Trans. I. 1:1992;1173-1178.
5. Briesmeister J. MCNP - A general Monte Carlo n-particle transport code. MCNP User's Manual. 1993;Los Alamos National Laboratory, Los Alamos, TX.
6. Buchsbaum D.J., Langmuir V.K., Wessels B.W. Experimental radioimmunotherpy. Med. Phys. 20:1993;551-567.
7. 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts. Int. J. Radiat. Oncol. Biol. Phys. 25:1993;629-638.
8. Foster D. and Barrett P. (in press) Developing and testing integrated multicompartment models to describe a single-input multiple-output study using the SAAM II software system. Proceedings of the Sixth International Radiopharmaceutical Dosimetry Symposium, Oak Ridge Institute for Science and Educations, Oak Ridge, TN.
9. Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., Parks W.P. In vitro cultivation of human tumors Establishment of cell lines derived from a series of solid tumors . J. Natl. Cancer Inst. 51:1973;1417-1423.
10. Hui T., Fisher D.R., Kuhn J.A., Williams L.E., Nourigat C., Badger C.C., Beatty B.G., Beatty J.D. A mouse model for calculating cross-organ beta doses from yttrium-90-labeled immunoconjugates. Cancer. 73:(suppl.):1994;951-957.
11. Humm J.L. A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;1767-1773.
12. 213Bi. Brit. J. Cancer.
13. Kennel S.J., Lankford T., Hughes B., Hotchkiss J.A. Quantitation of a murine lung endothelial cell protein, P112, with a double monoclonal antibody assay. Lab. Invest. 59:1988;692-701.
14. 213Bi. Radiochim. Acta. 79:1997;87-91.
15. 213Bi - An α-particle emitter. Nucl. Med. Biol. 25:1998;241-246.
16. Kozak R.W., Raubitschek A., Mirzadeh S., Brechbiel M.W., Junghaus R., Gansow O.A., Waldmann T.A. Nature of the bifunctional chelating agent used for radioimmunotherapy with Yttrium-90 monoclonal antibodies Critical factors in determining in vivo survival and organ toxicity . Cancer Res. 49:1989;2639-2644.
17. Loevinger R., Budinger T. and Watson E. (1988) MIRD Primer for Absorbed Dose Calculations. Society for Nuclear Medicine, 128 pp.
18. Mordenti H. Man versus beast Pharmacokinetic scaling in mammals . J. Pharm. Sci. 75:1986;1028-1040.
19. 90Y antibody therapy of colon cancer xenografts in nude mice. Cancer Res. 50:1990;1008s-1010s.
20. Muthuswamy M.S., Roberson P.L., Haken R.K., Buchsbaaum D.J. A quantitative study of radionuclide characteristics for radioimmunotherapy from 3D reconstructions using serial autoradiography. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;165-172.
21. Press O.W., Shan D., Howell-Clark J., Eary J., Appelbaum F.R., Matthews D., King D.J., Haines A.M.R., Hamann P., Hinman L., Shochat D., Bernstein I.D. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells. Cancer Res. 56:1996;2123-2129.
22. Roeske J.C., Stinchcomb T.G. Dosimetric framework for therapeutic alpha-particle emitters. J. Nucl. Med. 38:1997;1923-1929.
23. Sharkey R.M., Motta-Hennessy C., Gansow O.A., Brechbiel M.W., Fand I., Griffiths G.L., Jones A.L., Goldenberg D.M. Selection of a DTPA chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice. Int. J. Cancer. 46:1990;79-85.
24. Siegel J.A., Stabin M.G. Absorbed fractions for electrons and beta particles in spheres of various sizes. J. Nucl. Med. 35:1994;152-156.
25. Spector W. Handbook of Biological Data. 1956;W. B. Saunders, Baltimore.
26. Terzaghi-Howe M. Inhibition of carcinogen-altered rat tracheal epithelial cell proliferation by normal epithelial cell proliferation by normal cells in vivo. Carcinogenesis. 8:1987;145-150.
27. 32P colloids in a murine intraperitoneal tumor model. Gynecol. Oncol. 47:1992;366-372.
28. Waldmann T.A., White J.D., Carrasquillo J.A., Reynolds J.C., Paik C.H., Gansow O.A., Brechbiel M.W., Jaffe E.S., Fleisher T.A., Goldman C.K., et al. Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood. 86:1995;4063-4075.
29. Wong J.Y.C., Williams L.E., Demidecki A.J., Wessels B.W., Yan X.W. Radiobiologic studies comparing Yttrium-90 irradiation and external beam irradiation in vitro. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;715-722.
30. Wu C., Kobayashi H., Sun B., Yoo T.M., Paik C.H., Gansow O.A., Carrasquillo J.A., Pastan I., Brechbiel M.W. Stereochemical influence on the stability of radio-metal complexes in vivo. Synthesis evaluation of the four steroisomers of 2-(p- Nitrobenzyl)-trans-CyDTPA. Bioorganic Med. Chem. 5:(10):1997;1925-1934.
31. Yoriyaz H., Stabin M. Electron and photon transport in a model of a 30-g mouse. J. Nucl. Med. 38:(suppl.):1997;228.
32. Zalutsky M.R., Bigner D. Radioimmunotherapy with α-particle emitting radioimmuno-conjugates. Acta Oncol. 35:1996;373-379.